141 related articles for article (PubMed ID: 2570656)
1. Healing and recurrence of active duodenal ulcer with nizatidine.
Cloud ML; Offen WW; Matsumoto C; Chernish SM
Clin Pharmacol Ther; 1989 Sep; 46(3):310-6. PubMed ID: 2570656
[TBL] [Abstract][Full Text] [Related]
2. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
Cherner JA; Cloud ML; Offen WW; Latz JE
Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
[TBL] [Abstract][Full Text] [Related]
3. Treatment of duodenal ulceration in the United States.
Dyck WP; Cloud ML; Offen WW; Matsumoto C; Chernish SM
Scand J Gastroenterol Suppl; 1987; 136():47-55. PubMed ID: 2892255
[TBL] [Abstract][Full Text] [Related]
4. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
[TBL] [Abstract][Full Text] [Related]
5. Nizatidine as maintenance therapy of duodenal ulcer disease in remission.
Cerulli MA; Cloud ML; Offen WW; Chernish SM; Matsumoto C
Scand J Gastroenterol Suppl; 1987; 136():79-83. PubMed ID: 2892259
[TBL] [Abstract][Full Text] [Related]
6. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
Naccaratto R; Cremer M; Dammann HG; Keohane PP; Mulder H; Sarles H; Simon B
Scand J Gastroenterol Suppl; 1987; 136():71-8. PubMed ID: 2892258
[TBL] [Abstract][Full Text] [Related]
7. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
Levendoglu H; Mehta B; Wait C; Reddy G; Hatcher C
Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607
[TBL] [Abstract][Full Text] [Related]
8. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
[TBL] [Abstract][Full Text] [Related]
9. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
Arnold R; Beckenbach P; Bock H; Bormann R; Daake H; Dammann HG; Du Bosque G; Fürer M; Geiter B; Hebbeln H
Fortschr Med; 1989 Jul; 107(21):467-70. PubMed ID: 2570012
[TBL] [Abstract][Full Text] [Related]
10. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
Bovero E; Poletti M; Boero A; Mura BC; Camarri E; Corradini P; Corsini G; Federici G; Curzio M; Gianquinto G
Hepatogastroenterology; 1987 Dec; 34(6):269-71. PubMed ID: 2892768
[TBL] [Abstract][Full Text] [Related]
11. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
Lima M; Holdcroft C
Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
[TBL] [Abstract][Full Text] [Related]
12. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
Pace F; Colombo E; Ferrara A; Prada A; Rocca F; Bianchi Porro G
Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
[TBL] [Abstract][Full Text] [Related]
13. Twice-daily sucralfate dosing to heal acute duodenal ulcer. Multicenter Study Group.
Schubert T
Am J Med; 1989 Jun; 86(6A):108-12. PubMed ID: 2660551
[TBL] [Abstract][Full Text] [Related]
14. Comparison of famotidine 40 mg with ranitidine 300 mg at night in short-term duodenal ulcer healing. A South African multicentre study.
Marks IN; Wright JP
S Afr Med J; 1987 Jul; 72(1):18-20. PubMed ID: 2885928
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
[TBL] [Abstract][Full Text] [Related]
16. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Price AH; Brogden RN
Drugs; 1988 Nov; 36(5):521-39. PubMed ID: 2905640
[TBL] [Abstract][Full Text] [Related]
17. A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis.
Quik RF; Cooper MJ; Gleeson M; Hentschel E; Schuetze K; Kingston RD; Mitchell M
Aliment Pharmacol Ther; 1990 Apr; 4(2):201-11. PubMed ID: 1983322
[TBL] [Abstract][Full Text] [Related]
18. Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing.
Reynolds JC
Ann Intern Med; 1989 Jul; 111(1):7-14. PubMed ID: 2567589
[TBL] [Abstract][Full Text] [Related]
19. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study.
Texter EC; Navab F; Mantell G; Berman R
Am J Med; 1986 Oct; 81(4B):25-32. PubMed ID: 2877571
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease.
Gitlin N; McCullough AJ; Smith JL; Mantell G; Berman R
Gastroenterology; 1987 Jan; 92(1):48-53. PubMed ID: 2877912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
